Experts agree that 2024 will be the year AI invades and transforms work as we know it, raising the question of whether the take over will compromise workplace humanity.
Share this article
Share this article
Grant to support MIGAL s groundbreaking research into treatments for Colitis and Crohn s Disease led by Dr. Dorit Avni
QIRYAT SHMONA, Israel, Feb. 1, 2021 /PRNewswire/ The MIGAL Galilee Research Institute (MIGAL) a regional mega-R&D center supported by Israel s Ministry of Science and Technology, today announced that ALGAE4IBD, a project initiated, led and coordinated by Dr. Dorit Avni, the group leader of MIGAL s Bioactive Metabolites and Immune Modulation Laboratory, has been awarded a prestigious EU (European Union) HORIZON 2020 R&D grant in the amount of EUR 7.5 million.
The aim of the grant is to promote a breakthrough in the development of natural ingredients from algae, leveraging their unique capabilities to develop novel treatments for inflammatory diseases with no existing cures, such as Inflammatory Bowel Disease (IBD); Colitis and Crohn s Disease.